The growth media for the cell lines CHP-212 and IMR-32 listed in Table 1 of this Data Descriptor were incorrectly stated.
• For the cell line CHP-212, the correct growth medium is: EMEM (with non-essential amino acids) and Ham′s F12 (1:1 mixture), 10% FBS, 1% Penicillin/Streptomycin, 2 mM L-Glutamine.
• For the cell line IMR-32, the correct growth medium is: EMEM (with non-essential amino acids), 10% FBS, 1% Penicillin/Streptomycin, 2 mM L-Glutamine.
• The COG cell lines were grown in antibiotic-free medium.
The cell line labelled as 'NB-16' in Fig. 2 , Table 1, and Table 2 was incorrectly recorded. The cell line should be listed as the rhabdomyosarcoma cell line, RD. GEO Series GSE89969 has been updated to reflect this error. We subsequently re-performed every analysis in the paper following exclusion of NB-16 and none of the conclusions of the manuscript change. As expected, all cell line-patient correlations are slightly higher (e.g.,: Cell Line-Patient Log2Expression R with NB-16 = 0.824, Cell Line-Patient Log2Expression R without NB-16 = 0.831). All other cell lines have been properly STR-verified using www.atcc.org and www.cogcell.org, and are labelled correctly.
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